Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication

MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor

(2017) K. P. C. Kuypers et al.   PSYCHOPHARMACOLOGY

MDMA-Induced Dissociative State not Mediated by the 5-HT2A Receptor

(2017) Drew J. Puxty et al.   Frontiers in Pharmacology

Keep off the grass? Cannabis, cognition and addiction

(2016) H. Valerie Curran et al.   NATURE REVIEWS NEUROSCIENCE

Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective

(2016) Kim P. C. Kuypers et al.   PLoS One

Circadian Rhythm of Circulating Levels of the Endocannabinoid 2-Arachidonoylglycerol

(2015) E. C. Hanlon et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Analysis of ECs and related compounds in plasma: artifactual isomerization and ex vivo enzymatic generation of 2-MGs

(2014) Antoni Pastor et al.   JOURNAL OF LIPID RESEARCH

Memory and mood during MDMA intoxication, with and without memantine pretreatment

(2014) E.B. de Sousa Fernandes Perna et al.   NEUROPHARMACOLOGY

Modulation of 3,4-Methylenedioxymethamphetamine Effects by Endocannabinoid System

(2013) Olga Valverde et al.   CURRENT PHARMACEUTICAL DESIGN

Inhibition of MDMA-induced increase in cortisol does not prevent acute impairment of verbal memory

(2012) KPC Kuypers et al.   BRITISH JOURNAL OF PHARMACOLOGY

Effects of Acute MDMA Intoxication on Mood and Impulsivity: Role of the 5-HT2 and 5-HT1 Receptors

(2012) Janelle H. P. van Wel et al.   PLoS One

In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin2A Receptor Binding in 3,4-Methylenedioxymethamphetamine (MDMA or “Ecstasy”) and Hallucinogen Users

(2011) David Erritzoe et al.   ARCHIVES OF GENERAL PSYCHIATRY

Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses

(2011) Arnau Busquets-Garcia et al.   BIOLOGICAL PSYCHIATRY

Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans

(2011) AR Green et al.   BRITISH JOURNAL OF PHARMACOLOGY

Modulation of the serotonin system by endocannabinoid signaling

(2011) Samir Haj-Dahmane et al.   NEUROPHARMACOLOGY

Blockade of 5-HT2 Receptor Selectively Prevents MDMA-Induced Verbal Memory Impairment

(2011) J H P van Wel et al.   NEUROPSYCHOPHARMACOLOGY

Endocannabinoid signalling: has it got rhythm?

(2010) Linda K Vaughn et al.   BRITISH JOURNAL OF PHARMACOLOGY

Central and Peripheral Endocannabinoids and Cognate Acylethanolamides in Humans: Association with Race, Adiposity, and Energy Expenditure

(2010) Reiner Jumpertz et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers

(2010) GJH Dumont et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis

(2009) David R Janero et al.   EXPERT OPINION ON EMERGING DRUGS

A Cannabinoid CB1 Receptor Antagonist Ameliorates Impairment of Recognition Memory on Withdrawal from MDMA (Ecstasy)

(2009) Yoko Nawata et al.   NEUROPSYCHOPHARMACOLOGY

Involvement of Inferior Parietal Lobules in Prospective Memory Impairment during Acute MDMA (Ecstasy) Intoxication: An Event-Related fMRI Study

(2008) Johannes G Ramaekers et al.   NEUROPSYCHOPHARMACOLOGY